Researchers aim to make red blood cells from stem cells

The Defense Advanced Research Projects Agency is launching a "blood pharming" program that aims to create a battlefield system to produce red blood cells derived from progenitor cells for use in blood transfusions. The program, however, has to overcome several challenges, including the large volume of cells required for transfusions and the uncertainty of how these manufactured cells would function in the body.

View Full Article in:

New York Times (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care